Perseo pharma AG
|Category:||Emerging Biotech Company Presentation|
|Time:||17:15 – 17:30|
|Speaker:||Dr. Yves Dudal|
We are breaking new ground in the treatment of digestive diseases.
Our goal is to develop a series of innovative patient-centered oral enzyme digestive therapies based on our proprietary nanotechnology platform.
Twelve months away from the clinics, we are a fast-growing company engaged in early partnering for the joint development of our rich pipeline.